BRD7 plays an anti-inflammatory role during early acute inflammation by inhibiting activation of the NF-кB signaling pathway
Open Access
- 4 July 2016
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cellular & Molecular Immunology
- Vol. 14 (10), 830-841
- https://doi.org/10.1038/cmi.2016.31
Abstract
Increasing evidence has shown a strong association between tumor-suppressor genes and inflammation. However, the role of BRD7 as a novel tumor suppressor in inflammation remains unknown. In this study, by observing BRD7 knockout mice for 6–12 months, we discovered that compared with BRD7+/+ mice, BRD7−/− mice were more prone to inflammation, such as external inflammation and abdominal abscess. By using mouse embryo fibroblast (MEF) cells from the BRD7 knockout mouse, an in vitro lipopolysaccharide (LPS)-stimulated MEF cell line was established. The mRNA levels of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), chemokine (C-X-C motif) ligand 1 (CXCL-1) and inducible nitric oxide synthase (iNOS) were significantly increased in BRD7−/− MEF cells compared with BRD7+/+ MEF cells after LPS stimulation for 1 or 6 h. In addition, the cytoplasm-to-nucleus translocation of nuclear factor kappa-B (NF-κB; p65) and an increased NF-κB reporter activity were observed in BRD7−/− MEF cells at the 1 h time point but not at the 6 h time point. Furthermore, an in vivo dextran sodium sulfate (DSS)-induced acute colitis model was created. As expected, the disease activity index (DAI) value was significantly increased in the BRD7−/− mice after DSS treatment for 1–5 days, which was demonstrated by the presence of a significantly shorter colon, splenomegaly and tissue damage. Moreover, higher expression levels of IL-6, TNF-α, p65, CXCL-1 and iNOS, and an increased level of NF-κB (p65) nuclear translocation were also found in the DSS-treated BRD7−/− mice. These findings suggest that BRD7 has an anti-inflammatory role during early acute inflammation by inhibiting activation of the NF-кB signaling pathway, which provides evidence to aid in understanding the therapeutic effects of BRD7 on inflammatory diseases.Keywords
This publication has 54 references indexed in Scilit:
- Antiviral Activity of Recombinant Mouse β-defensin 3 against Influenza a Virusin vitroandin vivoAntiviral Chemistry and Chemotherapy, 2012
- The testis-specific double bromodomain-containing protein BRDT forms a complex with multiple spliceosome components and is required for mRNA splicing and 3′-UTR truncation in round spermatidsNucleic Acids Research, 2012
- Cathelicidin Signaling via the Toll-like Receptor Protects Against Colitis in MiceGastroenterology, 2011
- Inflammation-induced loss of Pdcd4 is mediated by phosphorylation-dependent degradationCarcinogenesis: Integrative Cancer Research, 2011
- IL‐27 inhibits OSM‐mediated TNF‐α and iNOS gene expression in microgliaGlia, 2010
- BRD7, a Novel PBAF-specific SWI/SNF Subunit, Is Required for Target Gene Activation and Repression in Embryonic Stem CellsJournal of Biological Chemistry, 2008
- Solution structure of BRD7 bromodomain and its interaction with acetylated peptides from histone H3 and H4Biochemical and Biophysical Research Communications, 2007
- Chemically induced mouse models of intestinal inflammationNature Protocols, 2007
- Is NF-κB a culprit in type 2 diabetes?Biochemical and Biophysical Research Communications, 2005
- NF-κB in cancer: from innocent bystander to major culpritNature Reviews Cancer, 2002